27.09.2014 Views

Program - Society of Toxicology

Program - Society of Toxicology

Program - Society of Toxicology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

50 th Anniversary Annual Meeting and ToxExpo<br />

<strong>Program</strong> Description (Continued)<br />

MONday<br />

Abstract # Abstract #<br />

#142 Poster Board Number.....................................231<br />

EFFECTS OF GENETIC VARIATION IN<br />

ENZYME CYTOCHROME P450 2D6 ON<br />

XENOBIOTIC METABOLISM THROUGH IN<br />

SILICO MOLECULAR DOCKING MODELS. ​<br />

C. B. Tolson 1,2 , Y. Tie 1 and E. Demchuk 1 . 1 Division<br />

<strong>Toxicology</strong> & Environmental Medicine, ATSDR/<br />

CDC, Atlanta, GA and 2 Biomedical Engineering,<br />

Georgia Institute <strong>of</strong> Technology, Atlanta, GA.<br />

Sponsor: B. Fowler.<br />

#143 Poster Board Number.....................................232<br />

INCORPORATION OF TOXCAST IN VITRO<br />

ASSAY DATA AND RELEVANT TOXICITY<br />

PATHWAY INFORMATION IMPROVES THE<br />

EXTERNAL PREDICTION ACCURACY OF<br />

QUANTITATIVE STRUCTURE-ACTIVITY<br />

RELATIONSHIP (QSAR) MODELS OF<br />

CHEMICAL HEPATOTOXICITY. ​H. Zhu, L.<br />

Zhang, J. Staab, A. Sedykh, H. Tang, S. Gomez, I.<br />

Rusyn and A. Tropsha. University <strong>of</strong> North Carolina<br />

at Chapel Hill, Chapel Hill, NC.<br />

#144 Poster Board Number.....................................233<br />

COMPUTATIONAL DOCKING OF THE<br />

ISOMERS OF NONYLPHENOL TO THE<br />

LIGAND BINDING DOMAIN OF THE<br />

ESTROGEN RECEPTOR. ​J. Rabinowitz and S.<br />

Little. NCCT/ORD /U.S. EPA, Research Triangle<br />

Park, NC.<br />

#145 Poster Board Number.....................................234<br />

ANALYSIS OF RELATIVE<br />

ROSIGLITAZONE, PIOGLITAZONE, AND<br />

EPIRUBICIN CARDIOTOXICITY IN RATS<br />

USING HISTORICAL MICROARRAY DATA. ​<br />

H. Zhou and T. J. Colatsky. CDER/OPS/OTR/DAPR,<br />

U.S. FDA, Silver Spring, MD.<br />

#146 Poster Board Number.....................................235<br />

COMPUTATIONAL MODELING<br />

FOR QT PROLONGATION: A DRUG<br />

CARDIOVASCULAR SAFETY ENDPOINT OF<br />

PARAMOUNT IMPORTANCE. ​L. G. Valerio 1 ,<br />

J. Prous Blancafort 2 , A. Valencia 2 and X. Mensa 2 .<br />

1<br />

CDER/OPS, U.S. FDA, Silver Spring, MD and<br />

2<br />

Prous Institute for Biomedical Research, Barcelona,<br />

Spain. Sponsor: N. Sadrieh.<br />

#147 Poster Board Number.....................................236<br />

TRANSLATABILITY OF DRUG-INDUCED<br />

CARDIOTOXICITY MOLECULAR<br />

MECHANISMS FROM IN VIVO TO IN<br />

VITRO. ​A. Enayetallah 1 , D. Puppala 1 , D. Ziemek 2 ,<br />

N. Greene 1 , Y. Will 1 and M. Pletcher 1 . 1 Compound<br />

Safety Prediction-PGRD, Pfizer Inc., Groton, CT<br />

and 2 Computational Sciences CoE, Pfizer Inc.,<br />

Cambridge, MA.<br />

#148 Poster Board Number.....................................237<br />

ASSOCIATION NETWORKS AND<br />

VISUALIZATION TOOLS TO CORRELATE<br />

PRECLINICAL SIGNALS TO DRUG-<br />

INDUCED NAUSEA IN MAN. ​J. Glab 1 ,<br />

M. Clark 2 , J. Valentin 1 and L. Ewart 1 . 1 Safety<br />

Pharmacology, AstraZeneca, Alderley Park, United<br />

Kingdom and 2 Discovery Information, AstraZeneca,<br />

Wilmington, DE.<br />

#149 Poster Board Number.....................................238<br />

DDT AND TCDD INTERACT WITH<br />

PROTEINS INVOLVED IN THE INSULIN<br />

RECEPTOR SIGNALING. ​M. Cabarcas-<br />

Montalvo, D. Montes-Grajales and J. Olivero-Verbel.<br />

Environmental and Computational Chemistry Group,<br />

University <strong>of</strong> Cartagena, Cartagena, Colombia.<br />

#150 Poster Board Number.....................................239<br />

COMPUTATIONAL BASED APPROACHES<br />

FOR IDENTIFYING AND UNDERSTANDING<br />

KINASES ASSOCIATED WITH<br />

CARDIOTOXICITY. ​D. Puppala 1 , V. Bonato 2 ,<br />

K. Leach 1 , S. Louise-May 1 , K. J. McConnell 3 , M.<br />

Gosink 4 and M. T. Pletcher 1 . 1 Compound Safety<br />

Prediction, Pfizer Inc., Groton, CT, 2 Biostatistics<br />

Group, Pfizer Inc., Groton, CT, 3 Computational<br />

Science CoE, Pfizer Inc., Groton, CT and 4 DSRD,<br />

Pfizer Inc., Groton, CT.<br />

#151 Poster Board Number.....................................240<br />

DISCOVERY OF NOVEL MICRO-RNAS<br />

FROM RAT LYMPHOCYTES DURING<br />

GLUCOCORTICOID INDUCED APOPTOSIS. ​<br />

R. Shah 1 , S. Vasa 1 , L. Smith 2 and J. Cidlowski 2 . 1 SRA<br />

International, Durham, NC and 2 National Institute<br />

<strong>of</strong> Environmental Health Science, Research Triangle<br />

Park, NC.<br />

#152 Poster Board Number.....................................241<br />

AUTOMATIC IN SILICO ASSESSMENT OF<br />

GENOTOXIC POTENTIAL IMPURITIES. ​A.<br />

Brigo, G. Gerebtz<strong>of</strong>f, M. Kansy, T. Weiser and T.<br />

Singer. Nonclinical Safety, F. H<strong>of</strong>fmann-La Roche<br />

Ltd., Basel, Switzerland.<br />

#153 Poster Board Number.....................................242<br />

AUTOMATED IDENTIFICATION OF<br />

STRUCTURE-TOXICITY RELATIONSHIPS<br />

USING ATOM SIGNATURES. ​L. Carlsson,<br />

E. Ahlberg Helgee and S. Boyer. Computational<br />

<strong>Toxicology</strong>, AstraZeneca, Mölndal, Sweden.<br />

#154 Poster Board Number.....................................243<br />

COMPUTATIONAL ASSESSMENT OF<br />

REACTIVE METABOLITE RISK IN DRUG<br />

DISCOVERY USING MECHANISTIC<br />

ENSEMBLE MODELLING. ​S. Boyer 1 , C.<br />

Hasselgren 1 , L. Peterlin-Masic 2 , O. Spjuth 3 and L.<br />

Carlsson 1 . 1 Computational <strong>Toxicology</strong>, AstraZeneca,<br />

Mölndal, Sweden, 2 Faculty <strong>of</strong> Pharmacy, University<br />

<strong>of</strong> Ljubljana, Ljubljana, Slovenia and 3 Department<br />

<strong>of</strong> Pharmaceutical Biosciences, Uppsala University,<br />

Uppsala, Sweden.<br />

#155 Poster Board Number.....................................244<br />

DESIGN AND DEVELOPMENT OF AN<br />

INSTITUTIONAL KNOWLEDGE-BASE<br />

AT FDA’S CENTER FOR FOOD SAFETY<br />

AND APPLIED NUTRITION. ​K. Arvidson, A.<br />

McCarthy, C. Yang and D. Hristozov. CFSAN, U.S.<br />

FDA, College Park, MD.<br />

#156 Poster Board Number.....................................245<br />

PHARMACOLOGICAL PROFILE<br />

SIMILARITY – A RELEVANT METHOD<br />

FOR ANTICIPATION OF IN VIVO SAFETY? ​<br />

D. Muthas 1 , M. Rolf 2 , S. Matis-Mitchell 3 and S.<br />

Boyer 1 . 1 Global Safety Assessment, AstraZeneca<br />

R&D, Mölndal, Sweden, 2 Global Safety Assessment,<br />

AstraZeneca R&D, Alderly Park, United Kingdom<br />

and 3 Discovery Information, AstraZeneca R&D,<br />

Wilmington, DE.<br />

128<br />

Education-Career Development Sessions<br />

Exhibitor Hosted Sessions<br />

Featured Sessions<br />

Historical Highlights<br />

Informational Sessions<br />

Platform Sessions

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!